Massachusetts General Hospital and the Enbrel Royalty
Synopsis
Massachusetts General Hospital is considering selling its royalty interest in Enbrel, Amgen's blockbuster drug for the treatment of rheumatoid arthritis. In assessing whether to sell, and at what price, the hospital must determine its value to a potential buyer as well as its own value of the royalty income.
- Derechos de autor:
- 2005 HBS
Book Details
- Book Quality:
- ISBN-13:
- Publisher:
- Harvard Business Publishing
- Date of Addition:
- 2016-08-03T02:56:17Z
- Idioma:
- English
- Categorías:
- Usage Restrictions:
- This is a copyrighted book.